Tesamorelin is a synthetic peptide that belongs to a class of medications known as growth hormone-releasing hormones (GHRHs) [1, 2, 3]
A before-bed dose on an empty stomach, timed to the natural nighttime pulse, is a common approach
Predrag Sikirics group (School of Medicine, University of Zagreb, 1991 ) Most common experimental dose in animal studies: 10 g/kg intraperitoneally or per os, daily Standard targeted pathways: VEGFR2 angiogenesis, NO synthase , 5-HT2A serotonin receptor, dopamine D2 receptor Clinical program in Croatia halted at Phase 2 (Crohns disease) WADA Prohibited List: added in 2022 to category S0 (Non-Approved Substances) Reference sources (PubMed) Sikiric P
Nearly all these medications are administered by weekly injection, though there is one semaglutide oral tablet (Rybelsus) approved for diabetes
In severe cases, hammertoes (tight, painful toe tendons) may also develop